Clinical Trial Update: A Study of Axitinib in Advanced Carcinoid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial update for axitinib in advanced carcinoid tumors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Tumor

Drugs mentioned

• Axitinib (Axitinib)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Carcinoid Tumor | Phase 2 | Status: COMPLETED | Results posted: 2017-05-25